Agenda
This year’s theme:
“Capital, Management & Collaboration: local & global perspectives”
Agenda correct on 16 October 2013
|
16 October 2013 |
||
|
18.30-20.30 |
Drinks and early registration opens |
|
|
17 October 2013 MAIN CONFERENCE STARTS |
||
|
08.00 Registration Opens |
||
|
09.30 |
Welcome Roland Kozlowski, LSBC (Poland) |
|
|
9.45 Session: Private and Public VC Investment Chair: Oliver Murphy, Deloitte (PL) |
||
|
9.45 |
Talk: European VC and investment trends Kevin Johnson, Index Ventures (CH) |
|
|
10.15 |
Talk: The European Investment Fund as a fund of funds Ralf Emmerich, EIF (B) |
|
|
10.45 |
Talk: How to leverage private investments with public funding Krzysztof Senger Deloitte (PL) |
|
|
11.15 Coffee & Networking |
||
11.45 Session: Private-public partnership and its role in initiating the investment cycle Chair: Oliver Murphy, Deloitte (PL) |
||
|
11.45 |
Talk: Private Public Partnership: Bridge VC Leszek Grabarczyk, The National Centre for Research and Development; NCBR (Poland) |
|
|
12.00 |
Talk: The role of the Polish Agency for Enterprise Development in funding innovation. |
|
|
12.15 |
Public approaches to supporting life sciences in the UK lessons for Central Europe: Mark Treherne UKTI (UK) |
|
|
12.30 |
Panel Discussion: The pros and cons of Public Private Partnership and its Role in Assisting Development of Life Sciences Businesses
Moderator: Oliver Murphy
Derek Jones, Babraham Research Campus (UK)
Leszek Grabarczyk, The National Centre for Research and Development; NCBR (PL)
Ralf Emmerich, EIF (B)
Mark Treherne UKTI (UK)
|
|
13.15 Networking lunch |
||
|
14.15 Session: International Collaboration Chair: Mark Treherne |
||
|
Talk: Case study – Winning the deal and subsequent collaboration Phil Gould; Jadara Pharma (UK) |
||
|
14.45 |
Panel discussion: Winning the deal and subsequent collaboration the do’s and don’ts Mark Treherne Phil Gould; Jadara Pharma (UK) Pawel Przewiezlikowski, Selvita (Poland) Barry Kenny, Heptares (UK) Johannes Zanzinger, Boehringer Ingelheim Pharma GmbH & Co. (KG) Charles Brigden, Amgen (US) |
|
|
15.30 |
TEA & Networking |
|
|
16.15 |
Panel Discussion: The far east scene and gaining investment from the far east it is possible for capital intensive CE businesses Moderator: Philip Gould (UK) Ajoy Khandheria, Global Asia Partners (India)
Sven Rohmann, Burrill & Company, Burril (D) Jian Cao, RTC Innovation Ltd (UK) Stephen Rhind, Propharma Partners (UK) |
|
|
17.00 |
Conference close for the day |
|
|
19.15 |
Networking drinks and Conference Dinner |
|
|
18 October 2013 |
||
|
8.00 |
Round table discussion alternative forms of protecting pharmaceutical intellectual property + breakfast for around 25 people Przemysław Walasek, Taylor Wessing (Poland) |
|
|
Session Starts 9.15 Biologics – an opportunity for Central Europe Chair: Bartosz Walter, Polish Academy of Sciences (PL) |
||
|
9.15 |
Talk: The Biologics Scene Maria Bednarek, Medimune (US/UK) |
|
|
9.45 |
Panel Discussion: Biologics the future an opportunity for Central Europe; innovation or collaboration? Moderator: Roland Kozlowski Kevin FitzGerald; Activiomics (UK) Maria Bednarek, Medimune (US/UK) Johannes Zanzinger, Boehringer Ingelheim Pharma GmbH & Co. (KG) Piotr Zien, Polpharma (PL) |
|
|
10.30 |
Organisation Presentations Kare Riis Nielsen
Talk: Biobased Industries Consortium (Novozymes) (B) Ferenc Marofka; European Commission (B)
Talk: Horizon 2020: What is in for life sciences in Central Europe?
|
|
|
11.00 |
Coffee and networking |
|
|
11.30 |
Company presentations: Chair: Bartosz Walter, Polish Academy of Sciences (PL) Proteon Sp. z o.o. Blirt S.A. Numed Sp. z o.o. |
|
|
12.15 |
Panel discussion: The big picture – bringing it all together how to make money in life sciences. Moderator: Roland Kozlowski Antoine Papiernik, Sofinnova (France) Marek Orlowski, Orenore (Poland) John Miliad, NBGI Ventures (UK) Bill Mason, Sage Healthcare (UK) |
|
|
13.15 |
Summing up Roland Kozlowski, LSBC (PL) & Oliver Murphy, Deloitte (PL) |
|
|
13.30 |
Conference close |
|